Loeb Partners Corp increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 184.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,900 shares of the healthcare conglomerate’s stock after buying an additional 12,900 shares during the period. UnitedHealth Group comprises 1.3% of Loeb Partners Corp’s investment portfolio, making the stock its 21st largest holding. Loeb Partners Corp’s holdings in UnitedHealth Group were worth $4,388,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. KBC Group NV increased its stake in UnitedHealth Group by 4.7% during the 3rd quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock worth $63,416,000 after buying an additional 14,672 shares during the period. DekaBank Deutsche Girozentrale grew its holdings in UnitedHealth Group by 2.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after acquiring an additional 9,810 shares in the last quarter. Bainco International Investors grew its holdings in UnitedHealth Group by 5.4% during the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after acquiring an additional 4,202 shares in the last quarter. Toronto Dominion Bank grew its holdings in UnitedHealth Group by 69.1% during the 3rd quarter. Toronto Dominion Bank now owns 383,943 shares of the healthcare conglomerate’s stock worth $75,193,000 after acquiring an additional 156,892 shares in the last quarter. Finally, Norinchukin Bank The grew its holdings in UnitedHealth Group by 2.7% during the 3rd quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock worth $35,405,000 after acquiring an additional 4,838 shares in the last quarter. 86.78% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total value of $5,078,804.96. Following the completion of the sale, the insider now owns 173,229 shares in the company, valued at approximately $39,659,047.26. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the company’s stock in a transaction on Tuesday, January 23rd. The shares were sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the completion of the sale, the director now owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The disclosure for this sale can be found here. In the last quarter, insiders sold 67,015 shares of company stock valued at $15,635,599. 0.89% of the stock is owned by insiders.
Several research analysts have commented on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target for the company in a report on Saturday, January 20th. Argus boosted their price target on shares of UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 18th. Deutsche Bank boosted their price target on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Citigroup boosted their price target on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $259.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $245.14.
UnitedHealth Group Inc (NYSE:UNH) opened at $225.05 on Tuesday. UnitedHealth Group Inc has a twelve month low of $162.74 and a twelve month high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $220,491.67, a price-to-earnings ratio of 21.01, a PEG ratio of 1.33 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same quarter in the prior year, the firm earned $2.11 EPS. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis. sell-side analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.33%. UnitedHealth Group’s dividend payout ratio (DPR) is 28.01%.
COPYRIGHT VIOLATION NOTICE: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/03/20/unitedhealth-group-inc-unh-shares-bought-by-loeb-partners-corp.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.